Aurora Investment Managers, Llc. Sage Therapeutics, Inc. Transaction History

Aurora Investment Managers, Llc.

  • $156 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020
SELL
$25.95 - $43.15 $401,446 - $667,530
-15,470 Closed
0 $0
Q1 2020

Apr 24, 2020
BUY
$26.15 - $77.24 $59,125 - $174,639
2,261 Added 17.12%
15,470 $444,000
Q4 2019

Jan 21, 2020
BUY
$60.18 - $154.77 $794,917 - $2.04 Million
13,209 New
13,209 $954,000

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Aurora Investment Managers, Llc. Portfolio

Follow Aurora Investment Managers, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aurora Investment Managers, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Aurora Investment Managers, Llc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email